CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — Form 8-K
Filed November 4, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 62/100
What the filing says
Charles River (market cap ~$7.3B) reported Q3 2026 revenue of $982.7M (down 2.2% reported, +4.7% organic) and non-GAAP EPS of $3.09 (+27.2% YoY), driven by strong Discovery & Safety Assessment segment performance (+5.9% organic) and a $245.6M tax benefit from foreign jurisdictional tax legislation. The company raised full-year 2026 guidance: organic revenue growth to at least +1.5% (from 0-1.0%) and non-GAAP EPS midpoint to $11.35-$11.55 (from $11.15-$11.45), adding $0.15 at midpoint. Non-GAAP operating margin expanded 330 bps YoY to 23.0%.
Why this rating
Meaningful guidance raise with sustained organic growth recovery, strong margin expansion, and strategic progress offset by tax-driven EPS benefit being one-time. Real operating improvement relative to $7.3B market cap.
See more from November 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.